Searched for
INDIAN DRUG NORMS
Trade disruptions, API dependence, compliance costs: Pharma MSMEs spell out policy priorities on World MSME DayIndian pharmaceutical MSMEs are facing immense pressure from rising costs, supply chain woes, and stringent regulations. Industry represent...- India's stance on killing of 3 seafarers is strongest that can be, says Foreign Affairs Expert Robinder SachdevForeign affairs expert Robinder Sachdev believes the killing of three Indian seafarers by US forces constitutes a war crime. He suggests fa...
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities lost momentum after a positive start, with Nifty closing lower and broader markets declining sharply. Investor caution ahea...
- Tripura arrests 3,705 illegal migrants since 2022; 3,463 are BangladeshisA senior Home Department official stated that 965 Bangladeshi nationals were arrested in 2022, followed by 1,014 in 2023; 947 in 2024; and ...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- Mumbai watermelon case update: Stunning twist as no additives found in fruit by FDA, focus shifts to poison angleMumbai watermelon case: Investigations into the deaths of a Mumbai family have ruled out food adulteration, with FDA tests finding no conta...
- Compliance squeeze, global scrutiny redefine India’s $30 billion pharma export playbookAs global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.
- Central government workers seek wages based on five-member familiesCentral government employees are demanding a significant overhaul of their pay structure. They want the government to consider a family of ...
- Government in talks with various markets to accept Indian drug normsIndia is nudging various semi-regulated markets like Myanmar and Kenya to accept its drug standards, instead of the US or British norms.
- Drugs sold by company in the Indian market are safe: RanbaxyRanbaxy insisted drugs sold by it in the Indian market are safe and effective and the company complies with country's regulations.
- Uncertainty in regulatory regime forcing Indian firms like Biocon shift drug trials abroadBlame administrative lethargy, not judicial overreach, for regulatory vacuum, making India forgo a valuable economic activity, which raises...
- New US norms on statins to help Indian drug firmsCholesterol-reducing drugs worth nearly $15 billion (Rs 92,000 crore) were sold in the US in the year to September 2013, Bakhru wrote in hi...
- USFDA pulls up Smruthi Organics for norms violation in unitSmruthi Organics today said it has received a notification from the USFDA highlighting violations of manufacturing norms at its Solapur pla...
- India’s drug regulator asleep on the job?India must move in the direction of the US where drugmakers comply with stringent norms on quality and crackdown on unethical marketing pra...
- New drug pricing policy may affect Cadila & Cipla majorly: Bino Pathiparampil, IIFL"The new norms of the pharma pricing policy are a bit more stringent than the earlier norms that were put forward by the group of ministers...
- Govt plans separate quality norms for drugs and devicesThe government has decided to create separate quality guidelines for medical devices and not treat them as drugs.
- Centre to help drug cos meet stringent US quality lawsThe government has said that it will prepare the domestic drug industry to meet new regulatory challenges in the US market, which arose due...
- Domestic drug makers will not need GMP certificateDomestic drug makers will no longer need a certificate of good manufacturing practice (GMP) from WHO to sell their medicines within India.
- Drug cos face stricter checks on road to pricing freedomPharmaceutical companies will now have to face in-depth scientific scrutiny on how therapeutically useful are the ingredients that go into ...
Load More
